J Norman. Show Affiliations »
Abstract
Mesh: See more » Cost-Benefit AnalysisEnglandHealth ExpendituresHumansPacemaker, ArtificialState Medicine
Year: 1976 PMID: 54604 DOI: 10.1016/s0140-6736(76)90177-x
Source DB: PubMed Journal: Lancet ISSN: 0140-6736 Impact factor: 79.321